The Cigna Group Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)
The Cigna Group (CI) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) of $2.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss · last filed 2026-07-30
- The Cigna Group fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2026-06-30 was $2.00M, a 33.33% decline year-over-year.
- The Cigna Group fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2026-03-31 was -$3.00M, a 142.86% decline year-over-year.
- The Cigna Group fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2025-12-31 was $2.00M.
- The Cigna Group fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2025-09-30 was $21.00M, a 162.50% increase year-over-year.
- The Cigna Group fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2025 was $33.00M.
- The Cigna Group fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2024 was -$9.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00M 10-Q · filed 2026-07-30 | -$1.00M 10-Q · filed 2026-07-30 | $1.00M derived: sum of 3 quarters · filed 2026-07-30 | $22.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | -$3.00M 10-Q · filed 2026-04-30 | -$1.00M derived: sum of 2 quarters · filed 2026-04-30 | $20.00M derived: sum of 3 quarters · filed 2026-04-30 | $23.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.00M derived: sum of 2 quarters · filed 2026-02-26 | $26.00M derived: sum of 3 quarters · filed 2026-07-30 | $33.00M 10-K · filed 2026-02-26 |
| 2025-09-30 | $21.00M 10-Q · filed 2025-10-30 | $24.00M derived: sum of 2 quarters · filed 2026-07-30 | $31.00M 10-Q · filed 2025-10-30 | $19.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $3.00M 10-Q · filed 2026-07-30 | $10.00M 10-Q · filed 2026-07-30 | -$2.00M derived: sum of 3 quarters · filed 2026-07-30 | $6.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $7.00M 10-Q · filed 2026-04-30 | -$5.00M derived: sum of 2 quarters · filed 2026-04-30 | $3.00M derived: sum of 3 quarters · filed 2026-04-30 | |
| 2024-12-31 | -$12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.00M derived: sum of 2 quarters · filed 2026-02-26 | -$9.00M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $8.00M 10-Q · filed 2025-10-30 | $3.00M 10-Q · filed 2025-10-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |